NCT04558450招募中不适用
Covid-19 Effects on ARTErial StIffness and Vascular AgiNg
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 360
- 试验地点
- 6
- 主要终点
- PWV
研究概览
简要总结
The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.
详细描述
After being informed about the study and potential risks, all eligible patients giving written informed consent will undergo a comprehensive non-invasive assessment of vascular and cardiac function 6 months and 12 months after COVID-19 infection. Cardiovascular events and mortality will be collected 2, 5 and 10 years after inclusion
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age >18 years, both sexes;
- •written informed consent;
- •affiliation to a social security regime;
- •a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3)
- •hospitalization in intensive care unit for COVID19 (for group 1)
- •hospitalization in a medicine unit for COVID19 (for group 2)
- •no hospitalization for COVID19 or hospitalization less than 24h (for group 3)
- •a negative test for SARS-nCOV2 infection (PCR or serology)(for group 4)
排除标准
- •Age <18 years
- •Inability to express consent of the study
- •Diseases carrying out a life -expectancy <1 year according to clinical judgment
- •Pregnancy and breastfeeding
- •Foreseen inability to attend scheduled visits
结局指标
主要结局
PWV
时间窗: 12 months after COVID19 infection
carotid-femoral pulse wave velocity measured by application tonometry
PWV change
时间窗: difference between PWV at 12 and 6 months after COVID19 infection
carotid-femoral pulse wave velocity measured by application tonometry
次要结局
- wave separation/wave intensity analysis (WSA/WIA)(12 months after COVID19 infection)
- WSA/WIA change(difference between WSA/WIA at 12 and 6 months after COVID19 infection)
- cardiac diastolic dysfunction(12 months after COVID19 infection)
- cardiac diastolic dysfunction change(difference between cardiac diastolic dysfunction at 12 and 6 months after COVID19 infection)
- myocardial stiffness(12 months after COVID19 infection)
- myocardial stiffness change(difference between myocardial stiffness at 12 and 6 months after COVID19 infection)
- carotid femoral and hearth carotid change(6 months after COVID19 infection)
- arterial distensibility(12 months after COVID19 infection)
- arterial distensibility change(difference between arterial distensibility at 12 and 6 months after COVID19 infection)
- brachial artery FMD(12 months after COVID19 infection)
- brachial artery FMD change(difference between FMD at 12 and 6 months after COVID19 infection)
- central blood pressure(12 months after COVID19 infection)
- central blood pressure (BP) change(difference between central BP at 12 and 6 months after COVID19 infection)
研究者
研究点 (6)
Loading locations...
相似试验
Unknown
4 期
Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)De Novo Transplant DiseaseNCT02154854University Hospital, Tours104
招募中
Unknown
Evaluation of association of vascular aging, chronic inflammation and degenerative brain diseaseMental and behavioural disordersKCT0008806Gachon University Gil Medical Center350
已完成
不适用
Comparing an Automatic PWV Analyser to Pulse Pressure in HemodialysisVascular StiffnessNCT02327962Ospedale Regionale di Locarno143
已完成
不适用
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.Diabetes MellitusNCT03010956University of Athens100
Unknown
不适用
The Evaluations of Cardiovascular Changes in Long-term Treated HIV-infected IndividualsHIV/AIDSCardiovascular DiseasesNCT04463810Peking Union Medical College Hospital500